Extra Space Storage Inc. (NYSE: EXR) announced it will release its second-quarter 2026 financial results after the market closes on Tuesday, July 28, 2026. The company will host a conference call on Wednesday, July 29, 2026, at 1:00 p.m. Eastern Time, with CEO Joe Margolis, President Noah Springer, and Executive Vice President and CFO Jeff Norman to discuss the results. Registered financial analysts will have a Q&A session, and a live webcast will be available on the company's investor relations website.

Extra Space Storage (NYSE: EXR) announced it will release its Q2 2026 financial results after market close on Tuesday, July 28, 2026, covering the three and six months ended June 30, 2026. A conference call to discuss these results is scheduled for 1:00 p.m. ET on Wednesday, July 29, 2026. The webcast and replay will be available on the company's investor relations website, with CEO Joe Margolis leading the discussion.

Realty Income (NYSE: O) officer Neale Redington had 240 shares of common stock withheld to cover taxes on a stock grant of 477 shares issued on June 27, 2026. The shares were valued at $63.12 each. This transaction is a routine tax withholding, not an open-market sale, and Redington now directly holds 23,618 common shares.

Travelers Companies, a leading U.S. property-casualty insurer, is drawing investor attention due to its underwriting trends and catastrophe exposure. Analysts are focusing on the company's combined ratio, reserve development, and pricing trends across its diverse commercial and personal insurance lines. These factors, alongside investment income from its fixed-income portfolio, are key drivers for its earnings and valuation.

This article reports on the Form 4 filing for Realty Income Corp for June 30th. It is a brief announcement indicating the availability of this financial document, often associated with insider transactions. The core content is the title itself, with the rest of the page dedicated to market data and news unrelated to the specific Form 4 filing.

The Rosen Law Firm is reminding purchasers of Microsoft Corporation (NASDAQ: MSFT) common stock between May 1, 2025, and January 28, 2026, of the August 11, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Microsoft made false and misleading statements regarding problems with its Copilot products, its AI model's performance compared to competitors, and the need for significant capital expenditures to improve its AI offerings. Investors who purchased during this period may be entitled to compensation and are encouraged to join the class action.

A phase 1 LIMBER trial investigated INCB057643, a BET inhibitor, both as monotherapy and in combination with ruxolitinib for treating relapsed/refractory myelofibrosis and other myeloid neoplasms. The study demonstrated promising improvements in anemia, spleen size, and symptom burden, particularly with the combination therapy. While common adverse events included thrombocytopenia and anemia, the initial findings suggest the potential of INCB057643 combinations to improve clinical outcomes for patients.

OpenAI has hired former Uber Technologies India and South Asia President Prabhjeet Singh as its managing director for India, signaling a significant expansion into the country. Singh, who will report to Asia Pacific Managing Director Kiran Mani, will focus on growth, partnerships, and regulatory engagement to expand the AI ecosystem in India. This hire is part of a broader recruitment drive by OpenAI, which has recently added several other high-profile executives from companies like the White House, Ironclad, and Salesforce.

Alexander's, Inc. has secured a 15-year lease with Target Corporation for 135,000 square feet at its Rego Park Shopping Center in New York. This agreement brings the shopping center to 99% occupancy, following the recent sale of Alexander's Rego Park I property to Northwell Health for $235.5 million and the refinancing of the Rego Park Shopping Center for $175 million. The shopping center is anchored by several major retailers, indicating its strong market position.

Zimmer Biomet Holdings Inc (ZBH) shares recently dropped 5.6% to $86.09, which is 31.7% below its GF Value™ of $126.11, categorizing it as significantly undervalued. The company holds a GF Score™ of 76/100, indicating strong profitability and valuation, though financial strength and momentum are moderate. Insiders have sold $0.4 million in stock over the last three months with no buying activity, which could signal cautious sentiment.